A serological type II collagen neoepitope biomarker reflects cartilage breakdown in patients with osteoarthritis

OBJECTIVES: There is an unmet medical need for biomarkers in OA which can be applied in clinical drug development trials. The present study describes the development of a specific and robust assay measuring type II collagen degradation (T2CM) and discusses its potential as a noninvasive translationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Groen, Solveig Skovlund, Sinkeviciute, Dovile, Bay-Jensen, Anne-Christine, Thudium, Christian S., Karsdal, Morten A., Thomsen, Simon Francis, Lindemann, Sven, Werkmann, Daniela, Blair, Joseph, Staunstrup, Line Mærsk, Önnerfjord, Patrik, Arendt-Nielsen, Lars, Nielsen, Signe Holm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
ORIGINAL PAPER
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718155/
https://www.ncbi.nlm.nih.gov/pubmed/36474766
http://dx.doi.org/10.1016/j.ocarto.2021.100207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718155/
https://www.ncbi.nlm.nih.gov/pubmed/36474766
http://dx.doi.org/10.1016/j.ocarto.2021.100207

Ejemplares similares